QBIO - Q BioMed Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
16.89M
Enterprise Value 3
10.96M
Trailing P/E
N/A
Forward P/E 1
-3.37
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 3.56
52-Week Change 3-81.07%
S&P500 52-Week Change 318.10%
52 Week High 32.5400
52 Week Low 30.3400
50-Day Moving Average 30.4526
200-Day Moving Average 31.0265

Share Statistics

Avg Vol (3 month) 370.81k
Avg Vol (10 day) 370.64k
Shares Outstanding 516.72M
Float 12.87M
% Held by Insiders 125.97%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21000/2499
Last Split Date 3Aug 7, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Nov 30, 2018
Most Recent Quarter (mrq)Aug 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-626.29%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-9.91M
Diluted EPS (ttm)-0.6840
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)301.67k
Total Cash Per Share (mrq)0.02
Total Debt (mrq)4.65M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.12
Book Value Per Share (mrq)-0.40

Cash Flow Statement

Operating Cash Flow (ttm)-4.54M
Levered Free Cash Flow (ttm)-1.69M